Dynamic Capital Management Ltd lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 26.3% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 18,369 shares of the pharmacy operator’s stock after selling 6,550 shares during the period. Dynamic Capital Management Ltd’s holdings in Walgreens Boots Alliance were worth $1,526,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Fulton Bank N.A. boosted its stake in shares of Walgreens Boots Alliance by 41.4% in the first quarter. Fulton Bank N.A. now owns 3,531 shares of the pharmacy operator’s stock valued at $293,000 after buying an additional 1,034 shares in the last quarter. Burke & Herbert Bank & Trust Co. bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at about $270,000. Chesley Taft & Associates LLC boosted its stake in shares of Walgreens Boots Alliance by 1.4% in the first quarter. Chesley Taft & Associates LLC now owns 174,098 shares of the pharmacy operator’s stock valued at $14,459,000 after buying an additional 2,462 shares in the last quarter. Gulf International Bank UK Ltd boosted its stake in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Gulf International Bank UK Ltd now owns 286,363 shares of the pharmacy operator’s stock valued at $23,782,000 after buying an additional 4,970 shares in the last quarter. Finally, Lynch & Associates IN boosted its stake in shares of Walgreens Boots Alliance by 0.3% in the first quarter. Lynch & Associates IN now owns 46,177 shares of the pharmacy operator’s stock valued at $3,835,000 after buying an additional 125 shares in the last quarter. Hedge funds and other institutional investors own 61.17% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 0.55% during mid-day trading on Thursday, hitting $80.83. 279,650 shares of the stock traded hands. The firm has a 50 day moving average of $78.91 and a 200 day moving average of $82.32. The stock has a market cap of $86.50 billion, a price-to-earnings ratio of 20.41 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. During the same period in the prior year, the firm earned $1.18 EPS. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share buyback program on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%. Walgreens Boots Alliance’s dividend payout ratio is 37.78%.

TRADEMARK VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/10/walgreens-boots-alliance-inc-nasdaqwba-position-lowered-by-dynamic-capital-management-ltd.html.

Several brokerages recently issued reports on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Credit Suisse Group restated a “buy” rating and issued a $97.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. Leerink Swann set a $86.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, July 7th. Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Needham & Company LLC began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, June 27th. They issued a “hold” rating on the stock. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $90.69.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now directly owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.